Industry: Medical Devices & Consumables
Published Date: 2026-01-04
Pages: 174 Pages
Report ld: 5523417
Request Sample
Customized Report
PTCA Balloon Catheter Market Size(US$)

CAGR 2026-2032
9.6%
Market Size,2032
USD 2,461
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global PTCA Balloon Catheter market was valued at US$ 1306 million in 2025 and is anticipated to reach US$ 2461 million by 2032, at a CAGR of 9.6% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on PTCA Balloon Catheter competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The PTCA Balloon Catheter (Percutaneous Transluminal Coronary Angioplasty Balloon Catheter) is a vital device used in percutaneous coronary intervention (PCI) procedures, primarily for dilating coronary arteries narrowed or blocked due to atherosclerotic plaque. Its core functions include predilation of the lesion site, facilitating stent delivery, and post-dilation to enhance stent apposition and procedural outcomes. Based on compliance, PTCA balloon catheters are classified into two main types: semi-compliant and non-compliant. Semi-compliant balloons offer greater flexibility and moderate compliance, making them suitable for routine lesion preparation and navigating complex anatomies, while non-compliant balloons provide higher pressure resistance for post-dilation and treatment of calcified lesions. As cardiovascular disease continues to rise globally—particularly in aging populations—the role of PTCA balloon catheters has become increasingly central in interventional cardiology. The industry is steadily advancing toward thinner balloon walls, enhanced radiopacity, and improved trackability to meet evolving clinical demands.
Currently, PTCA balloon catheters represent a fundamental and essential component of coronary intervention procedures worldwide, with clinical use spanning predilation, stent delivery, and post-deployment optimization. With the continuous rise in PCI volumes globally, demand for these devices remains steady, particularly in high-incidence regions such as Asia-Pacific, Europe, and North America. The global market is dominated by major medical device manufacturers with strong brand recognition and distribution networks, while emerging economies are witnessing the rise of local manufacturers, driven by procurement cost control and government-led price regulation policies.
Looking ahead, product development will be guided by trends toward minimal invasiveness, operational efficiency, and treatment precision. Advances in materials science are driving balloon catheters toward thinner walls, enhanced radiopacity, lower crossing profiles, and improved flexibility. At the same time, integration with smart technologies such as imaging guidance and pressure-sensing capabilities is under active development, aiming to enhance procedural accuracy and enable more personalized interventions. Geographically, Latin America, Africa, and parts of Southeast Asia are expected to emerge as new growth drivers, supported by expanding healthcare infrastructure and favorable policy initiatives.
Nevertheless, the market faces notable challenges. Product homogeneity across manufacturers has intensified price competition, compressing margins across the industry. Globally tightening procurement regulations require companies to maintain compliance while balancing cost control and continued innovation investment. Moreover, expanding clinical indications for advanced balloon types and increasingly complex regulatory pathways have raised the barriers and timelines for market entry. To remain competitive, manufacturers must strengthen local service capabilities and pursue differentiated product strategies to sustain long-term growth in an increasingly crowded global marketplace.
This report delivers a comprehensive overview of the global PTCA Balloon Catheter market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding PTCA Balloon Catheter. The PTCA Balloon Catheter market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global PTCA Balloon Catheter market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist PTCA Balloon Catheter manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for PTCA Balloon Catheter manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines PTCA Balloon Catheter sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 PTCA Balloon Catheter Market Overview
1.1 Product Definition
1.2 PTCA Balloon Catheter by Type
1.2.1 Global PTCA Balloon Catheter Market Value by Type: 2025 vs 2032
1.2.2 Semi-Compliant
1.2.3 Non Compliant
1.3 PTCA Balloon Catheter by Application
1.3.1 Global PTCA Balloon Catheter Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.4 Global PTCA Balloon Catheter Market Size Estimates and Forecasts
1.4.1 Global PTCA Balloon Catheter Revenue 2021–2032
1.4.2 Global PTCA Balloon Catheter Sales 2021–2032
1.4.3 Global PTCA Balloon Catheter Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 PTCA Balloon Catheter Market Competition by Manufacturers
2.1 Global PTCA Balloon Catheter Sales Market Share by Manufacturers (2021–2026)
2.2 Global PTCA Balloon Catheter Revenue Market Share by Manufacturers (2021–2026)
2.3 Global PTCA Balloon Catheter Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of PTCA Balloon Catheter, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of PTCA Balloon Catheter, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of PTCA Balloon Catheter, Product Types and Applications
2.7 Global Key Manufacturers of PTCA Balloon Catheter, Date of Entry into the Industry
2.8 Global PTCA Balloon Catheter Market Competitive Situation and Trends
2.8.1 Global PTCA Balloon Catheter Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global PTCA Balloon Catheter Players Market Share by Revenue
2.8.3 Global PTCA Balloon Catheter Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global PTCA Balloon Catheter Market Scenario by Region
3.1 Global PTCA Balloon Catheter Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global PTCA Balloon Catheter Sales by Region: 2021–2032
3.2.1 Global PTCA Balloon Catheter Sales by Region: 2021–2026
3.2.2 Global PTCA Balloon Catheter Sales by Region: 2027–2032
3.3 Global PTCA Balloon Catheter Revenue by Region: 2021–2032
3.3.1 Global PTCA Balloon Catheter Revenue by Region: 2021–2026
3.3.2 Global PTCA Balloon Catheter Revenue by Region: 2027–2032
3.4 North America PTCA Balloon Catheter Market Facts & Figures by Country
3.4.1 North America PTCA Balloon Catheter Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America PTCA Balloon Catheter Sales by Country (2021–2032)
3.4.3 North America PTCA Balloon Catheter Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PTCA Balloon Catheter Market Facts & Figures by Country
3.5.1 Europe PTCA Balloon Catheter Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe PTCA Balloon Catheter Sales by Country (2021–2032)
3.5.3 Europe PTCA Balloon Catheter Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PTCA Balloon Catheter Market Facts & Figures by Region
3.6.1 Asia Pacific PTCA Balloon Catheter Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific PTCA Balloon Catheter Sales by Region (2021–2032)
3.6.3 Asia Pacific PTCA Balloon Catheter Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.7 Latin America PTCA Balloon Catheter Market Facts & Figures by Country
3.7.1 Latin America PTCA Balloon Catheter Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America PTCA Balloon Catheter Sales by Country (2021–2032)
3.7.3 Latin America PTCA Balloon Catheter Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.8 Middle East and Africa PTCA Balloon Catheter Market Facts & Figures by Country
3.8.1 Middle East and Africa PTCA Balloon Catheter Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa PTCA Balloon Catheter Sales by Country (2021–2032)
3.8.3 Middle East and Africa PTCA Balloon Catheter Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PTCA Balloon Catheter Sales by Type (2021–2032)
4.1.1 Global PTCA Balloon Catheter Sales by Type (2021–2026)
4.1.2 Global PTCA Balloon Catheter Sales by Type (2027–2032)
4.1.3 Global PTCA Balloon Catheter Sales Market Share by Type (2021–2032)
4.2 Global PTCA Balloon Catheter Revenue by Type (2021–2032)
4.2.1 Global PTCA Balloon Catheter Revenue by Type (2021–2026)
4.2.2 Global PTCA Balloon Catheter Revenue by Type (2027–2032)
4.2.3 Global PTCA Balloon Catheter Revenue Market Share by Type (2021–2032)
4.3 Global PTCA Balloon Catheter Price by Type (2021–2032)
5 Segment by Application
5.1 Global PTCA Balloon Catheter Sales by Application (2021–2032)
5.1.1 Global PTCA Balloon Catheter Sales by Application (2021–2026)
5.1.2 Global PTCA Balloon Catheter Sales by Application (2027–2032)
5.1.3 Global PTCA Balloon Catheter Sales Market Share by Application (2021–2032)
5.2 Global PTCA Balloon Catheter Revenue by Application (2021–2032)
5.2.1 Global PTCA Balloon Catheter Revenue by Application (2021–2026)
5.2.2 Global PTCA Balloon Catheter Revenue by Application (2027–2032)
5.2.3 Global PTCA Balloon Catheter Revenue Market Share by Application (2021–2032)
5.3 Global PTCA Balloon Catheter Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boston Scientific PTCA Balloon Catheter Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Abbott PTCA Balloon Catheter Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic PTCA Balloon Catheter Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Terumo
6.4.1 Terumo Company Information
6.4.2 Terumo Description and Business Overview
6.4.3 Terumo PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Terumo PTCA Balloon Catheter Product Portfolio
6.4.5 Terumo Recent Developments/Updates
6.5 Bluesail
6.5.1 Bluesail Company Information
6.5.2 Bluesail Description and Business Overview
6.5.3 Bluesail PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Bluesail PTCA Balloon Catheter Product Portfolio
6.5.5 Bluesail Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Company Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 B. Braun PTCA Balloon Catheter Product Portfolio
6.6.5 B. Braun Recent Developments/Updates
6.7 Acrostak
6.7.1 Acrostak Company Information
6.7.2 Acrostak Description and Business Overview
6.7.3 Acrostak PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Acrostak PTCA Balloon Catheter Product Portfolio
6.7.5 Acrostak Recent Developments/Updates
6.8 KANEKA
6.8.1 KANEKA Company Information
6.8.2 KANEKA Description and Business Overview
6.8.3 KANEKA PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 KANEKA PTCA Balloon Catheter Product Portfolio
6.8.5 KANEKA Recent Developments/Updates
6.9 GENOSS
6.9.1 GENOSS Company Information
6.9.2 GENOSS Description and Business Overview
6.9.3 GENOSS PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 GENOSS PTCA Balloon Catheter Product Portfolio
6.9.5 GENOSS Recent Developments/Updates
6.10 Biotronik
6.10.1 Biotronik Company Information
6.10.2 Biotronik Description and Business Overview
6.10.3 Biotronik PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Biotronik PTCA Balloon Catheter Product Portfolio
6.10.5 Biotronik Recent Developments/Updates
6.11 Translumina
6.11.1 Translumina Company Information
6.11.2 Translumina Description and Business Overview
6.11.3 Translumina PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Translumina PTCA Balloon Catheter Product Portfolio
6.11.5 Translumina Recent Developments/Updates
6.12 Alvimedica
6.12.1 Alvimedica Company Information
6.12.2 Alvimedica Description and Business Overview
6.12.3 Alvimedica PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Alvimedica PTCA Balloon Catheter Product Portfolio
6.12.5 Alvimedica Recent Developments/Updates
6.13 Cordis
6.13.1 Cordis Company Information
6.13.2 Cordis Description and Business Overview
6.13.3 Cordis PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Cordis PTCA Balloon Catheter Product Portfolio
6.13.5 Cordis Recent Developments/Updates
6.14 Balton
6.14.1 Balton Company Information
6.14.2 Balton Description and Business Overview
6.14.3 Balton PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Balton PTCA Balloon Catheter Product Portfolio
6.14.5 Balton Recent Developments/Updates
6.15 Hexacath
6.15.1 Hexacath Company Information
6.15.2 Hexacath Description and Business Overview
6.15.3 Hexacath PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Hexacath PTCA Balloon Catheter Product Portfolio
6.15.5 Hexacath Recent Developments/Updates
6.16 InSitu Technologies
6.16.1 InSitu Technologies Company Information
6.16.2 InSitu Technologies Description and Business Overview
6.16.3 InSitu Technologies PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 InSitu Technologies PTCA Balloon Catheter Product Portfolio
6.16.5 InSitu Technologies Recent Developments/Updates
6.17 Teleflex
6.17.1 Teleflex Company Information
6.17.2 Teleflex Description and Business Overview
6.17.3 Teleflex PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Teleflex PTCA Balloon Catheter Product Portfolio
6.17.5 Teleflex Recent Developments/Updates
6.18 MicroPort
6.18.1 MicroPort Company Information
6.18.2 MicroPort Description and Business Overview
6.18.3 MicroPort PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 MicroPort PTCA Balloon Catheter Product Portfolio
6.18.5 MicroPort Recent Developments/Updates
6.19 APT Medical
6.19.1 APT Medical Company Information
6.19.2 APT Medical Description and Business Overview
6.19.3 APT Medical PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 APT Medical PTCA Balloon Catheter Product Portfolio
6.19.5 APT Medical Recent Developments/Updates
6.20 BrosMed Medical
6.20.1 BrosMed Medical Company Information
6.20.2 BrosMed Medical Description and Business Overview
6.20.3 BrosMed Medical PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 BrosMed Medical PTCA Balloon Catheter Product Portfolio
6.20.5 BrosMed Medical Recent Developments/Updates
6.21 OrbusNeich Medical
6.21.1 OrbusNeich Medical Company Information
6.21.2 OrbusNeich Medical Description and Business Overview
6.21.3 OrbusNeich Medical PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 OrbusNeich Medical PTCA Balloon Catheter Product Portfolio
6.21.5 OrbusNeich Medical Recent Developments/Updates
6.22 Lepu Medical
6.22.1 Lepu Medical Company Information
6.22.2 Lepu Medical Description and Business Overview
6.22.3 Lepu Medical PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Lepu Medical PTCA Balloon Catheter Product Portfolio
6.22.5 Lepu Medical Recent Developments/Updates
6.23 Shunmei Medical
6.23.1 Shunmei Medical Company Information
6.23.2 Shunmei Medical Description and Business Overview
6.23.3 Shunmei Medical PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Shunmei Medical PTCA Balloon Catheter Product Portfolio
6.23.5 Shunmei Medical Recent Developments/Updates
6.24 Shanghai INT Medical
6.24.1 Shanghai INT Medical Company Information
6.24.2 Shanghai INT Medical Description and Business Overview
6.24.3 Shanghai INT Medical PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Shanghai INT Medical PTCA Balloon Catheter Product Portfolio
6.24.5 Shanghai INT Medical Recent Developments/Updates
6.25 Sinomed
6.25.1 Sinomed Company Information
6.25.2 Sinomed Description and Business Overview
6.25.3 Sinomed PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Sinomed PTCA Balloon Catheter Product Portfolio
6.25.5 Sinomed Recent Developments/Updates
6.26 Nanjing YDB Medical
6.26.1 Nanjing YDB Medical Company Information
6.26.2 Nanjing YDB Medical Description and Business Overview
6.26.3 Nanjing YDB Medical PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 Nanjing YDB Medical PTCA Balloon Catheter Product Portfolio
6.26.5 Nanjing YDB Medical Recent Developments/Updates
6.27 Zhejiang Barty Medical
6.27.1 Zhejiang Barty Medical Company Information
6.27.2 Zhejiang Barty Medical Description and Business Overview
6.27.3 Zhejiang Barty Medical PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.27.4 Zhejiang Barty Medical PTCA Balloon Catheter Product Portfolio
6.27.5 Zhejiang Barty Medical Recent Developments/Updates
6.28 Medoo Medical
6.28.1 Medoo Medical Company Information
6.28.2 Medoo Medical Description and Business Overview
6.28.3 Medoo Medical PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.28.4 Medoo Medical PTCA Balloon Catheter Product Portfolio
6.28.5 Medoo Medical Recent Developments/Updates
6.29 Yinyi Biotech
6.29.1 Yinyi Biotech Company Information
6.29.2 Yinyi Biotech Description and Business Overview
6.29.3 Yinyi Biotech PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.29.4 Yinyi Biotech PTCA Balloon Catheter Product Portfolio
6.29.5 Yinyi Biotech Recent Developments/Updates
6.30 HengYi Medical
6.30.1 HengYi Medical Company Information
6.30.2 HengYi Medical Description and Business Overview
6.30.3 HengYi Medical PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.30.4 HengYi Medical PTCA Balloon Catheter Product Portfolio
6.30.5 HengYi Medical Recent Developments/Updates
6.31 Demax Medical
6.31.1 Demax Medical Company Information
6.31.2 Demax Medical Description and Business Overview
6.31.3 Demax Medical PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.31.4 Demax Medical PTCA Balloon Catheter Product Portfolio
6.31.5 Demax Medical Recent Developments/Updates
6.32 DK Medical Technology
6.32.1 DK Medical Technology Company Information
6.32.2 DK Medical Technology Description and Business Overview
6.32.3 DK Medical Technology PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.32.4 DK Medical Technology PTCA Balloon Catheter Product Portfolio
6.32.5 DK Medical Technology Recent Developments/Updates
6.33 SCW Medicath
6.33.1 SCW Medicath Company Information
6.33.2 SCW Medicath Description and Business Overview
6.33.3 SCW Medicath PTCA Balloon Catheter Sales, Revenue, and Gross Margin (2021–2026)
6.33.4 SCW Medicath PTCA Balloon Catheter Product Portfolio
6.33.5 SCW Medicath Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PTCA Balloon Catheter Industry Chain Analysis
7.2 PTCA Balloon Catheter Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PTCA Balloon Catheter Production Mode & Process Analysis
7.4 PTCA Balloon Catheter Sales and Marketing
7.4.1 PTCA Balloon Catheter Sales Channels
7.4.2 PTCA Balloon Catheter Distributors
7.5 PTCA Balloon Catheter Customer Analysis
8 PTCA Balloon Catheter Market Dynamics
8.1 PTCA Balloon Catheter Industry Trends
8.2 PTCA Balloon Catheter Market Drivers
8.3 PTCA Balloon Catheter Market Challenges
8.4 PTCA Balloon Catheter Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global PTCA Balloon Catheter market size was US$ 1306 million in 2025 and is forecast to reach a readjusted size of US$ 2461 million by 2032 with a CAGR of 9.6% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 137
USD 4250.00
(Single User License)
The global market for PTCA Balloon Catheter was estimated to be worth US$ 1306 million in 2025 and is projected to reach US$ 2461 million, growing at a CAGR of 9.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 226
USD 3950.00
(Single User License)
The global PTCA Balloon Catheter market size was US$ 1205 million in 2024 and is forecast to a readjusted size of US$ 2265 million by 2031 with a CAGR of 9.6% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 149
USD 4250.00
(Single User License)
The global PTCA Balloon Catheter market is projected to grow from US$ 1205 million in 2024 to US$ 2265 million by 2031, at a CAGR of 9.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 239
USD 4900.00
(Single User License)
The global market for PTCA Balloon Catheter was estimated to be worth US$ 1205 million in 2024 and is forecast to a readjusted size of US$ 2265 million by 2031 with a CAGR of 9.6% during the forecast period 2025-2031.
Published Date: 2025-07-24
Pages: 217
USD 3950.00
(Single User License)
The global market for PTCA Balloon Catheter was valued at US$ 1205 million in the year 2024 and is projected to reach a revised size of US$ 2265 million by 2031, growing at a CAGR of 9.6% during the forecast period.
Published Date: 2025-07-24
Pages: 136
USD 2900.00
(Single User License)
In 2024, the global market size of PTCA Balloon Catheter was estimated to be worth US$ 1205 million and is forecast to reach approximately US$ 1760 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 158
USD 5900.00
(Single User License)
The global market for PTCA Balloon Catheter was estimated to be worth US$ 1205 million in 2024 and is forecast to a readjusted size of US$ 1760 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 121
USD 3950.00
(Single User License)
PTCA(经皮冠状动脉介入)球囊扩张导管是一种医疗设备,用于治疗冠状动脉疾病,特别是冠状动脉狭窄。该导管通过在病人的动脉中引入一个膨胀的球囊来扩张狭窄的动脉段。PTCA球囊扩张导管通过导管的内部将球囊引导到狭窄的位置,然后通过充气球囊来扩张动脉壁,从而恢复动脉的通畅性。这种介入治疗可以帮助改善心脏供血,减轻心绞痛症状,甚至可能避免心肌梗塞等严重并发症。
Published Date: 2024-05-17
Pages: 128
USD 4350.00
(Single User License)
PTCA(经皮冠状动脉介入)球囊扩张导管是一种医疗设备,用于治疗冠状动脉疾病,特别是冠状动脉狭窄。该导管通过在病人的动脉中引入一个膨胀的球囊来扩张狭窄的动脉段。PTCA球囊扩张导管通过导管的内部将球囊引导到狭窄的位置,然后通过充气球囊来扩张动脉壁,从而恢复动脉的通畅性。这种介入治疗可以帮助改善心脏供血,减轻心绞痛症状,甚至可能避免心肌梗塞等严重并发症。
Published Date: 2024-05-17
Pages: 122
USD 3950.00
(Single User License)
The global PTCA Balloon Catheter market size was US$ 1306 million in 2025 and is forecast to reach a readjusted size of US$ 2461 million by 2032 with a CAGR of 9.6% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 137
The global market for PTCA Balloon Catheter was estimated to be worth US$ 1306 million in 2025 and is projected to reach US$ 2461 million, growing at a CAGR of 9.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 226
The global PTCA Balloon Catheter market size was US$ 1205 million in 2024 and is forecast to a readjusted size of US$ 2265 million by 2031 with a CAGR of 9.6% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 149
The global PTCA Balloon Catheter market is projected to grow from US$ 1205 million in 2024 to US$ 2265 million by 2031, at a CAGR of 9.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 239
The global market for PTCA Balloon Catheter was estimated to be worth US$ 1205 million in 2024 and is forecast to a readjusted size of US$ 2265 million by 2031 with a CAGR of 9.6% during the forecast period 2025-2031.
Published: 2025-07-24
Pages: 217
The global market for PTCA Balloon Catheter was valued at US$ 1205 million in the year 2024 and is projected to reach a revised size of US$ 2265 million by 2031, growing at a CAGR of 9.6% during the forecast period.
Published: 2025-07-24
Pages: 136
In 2024, the global market size of PTCA Balloon Catheter was estimated to be worth US$ 1205 million and is forecast to reach approximately US$ 1760 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 158
The global market for PTCA Balloon Catheter was estimated to be worth US$ 1205 million in 2024 and is forecast to a readjusted size of US$ 1760 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 121
PTCA(经皮冠状动脉介入)球囊扩张导管是一种医疗设备,用于治疗冠状动脉疾病,特别是冠状动脉狭窄。该导管通过在病人的动脉中引入一个膨胀的球囊来扩张狭窄的动脉段。PTCA球囊扩张导管通过导管的内部将球囊引导到狭窄的位置,然后通过充气球囊来扩张动脉壁,从而恢复动脉的通畅性。这种介入治疗可以帮助改善心脏供血,减轻心绞痛症状,甚至可能避免心肌梗塞等严重并发症。
Published: 2024-05-17
Pages: 128
PTCA(经皮冠状动脉介入)球囊扩张导管是一种医疗设备,用于治疗冠状动脉疾病,特别是冠状动脉狭窄。该导管通过在病人的动脉中引入一个膨胀的球囊来扩张狭窄的动脉段。PTCA球囊扩张导管通过导管的内部将球囊引导到狭窄的位置,然后通过充气球囊来扩张动脉壁,从而恢复动脉的通畅性。这种介入治疗可以帮助改善心脏供血,减轻心绞痛症状,甚至可能避免心肌梗塞等严重并发症。
Published: 2024-05-17
Pages: 122
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now